Leukemia ikabije ya Lymphoblastic (T-ALL)-09

Umunyeshuri wo muri kaminuza witwa Mengmeng wo muri Yanjiao, Guizhou, yavuwe neza muri BIOOCUS Medical Group.

Mengmeng, umugore w'imyaka 21, yagejejwe mu ivuriro ryacu ryo hanze ku ya 22 Kamena 2021, afite umunaniro ukabije. Isuzuma ry’amaraso ryakozwe buri gihe ryagaragaje ko WBC 479 × 10 ^ 9 / L. Ibindi bipimo by’umusemburo w’amagufwa byemeje ko kanseri y’imitsi ikabije (T-cell leukemia) yanduye. Yakorewe imiti igabanya ubukana bwa kanseri inshuro ebyiri, ariko kanseri y’imitsi ntiyakira, MRD (indwara ntoya isigara) iri ku kigero cya 56.01%, kandi yari afite kanseri y’imitsi yo mu mutwe.

Ku ya 13 Kanama, hakusanyijwe lymphocytes zo mu bwoko bwa autologous hanyuma hatangwa imiti ivura indwara ya chimiotherapie. Ku ya 30 Kanama, Mengmeng yahawe CD7 CAR-T cells. Nyuma y'ibyumweru bibiri, isuzuma ry'umusemburo w'amagufwa ryagaragaje ko yakize burundu, MRD negatives, ndetse no kugenzura kanseri y'imitsi yo mu bwoko bwa cerebrovascular. Yagize ikibazo cyo kubura cytokine (CRS) mu cyiciro cya mbere nta ngaruka mbi zo mu mitsi yo mu bwoko bwa cerebrovascular.